CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.


Begin main content


Last Updated: December 15, 2005
Result type: Reports
Project Number: S0047
Product Line: Common Drug Review

Generic Name: Tipranavir

Brand Name: Aptivus

Manufacturer: Boehringer Ingelheim (Canada) Inc.

Indications: HIV infection

Submission Type: New

Project Status: Complete

Date Recommendation Issued: May 17, 2006

Recommendation Type: List with clinical criteria and/or conditions